基本情報
- 標準SMILES
Cc1ccnc2c1NC(=O)c1cccnc1N2C1CC1- InChIKey
NQDJXKOVJZTUJA-UHFFFAOYSA-N- 分子式
- C15H14N4O
- 平均分子量
- 266.3 g/mol
- 単同位体質量
- 266.11676108
名称と識別子
- 優先名称
- Nevirapine
- IUPAC
- 2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one
- 現地名
- ネビラピン
- 英語名
- Nevirapine
- 分子式
- C15H14N4O
- 分子量
- 266.3
名称と別名
名称をさらに表示
データベース識別子
- CAS
129618-40-2- PubChem CID
- 4463
- DTXSID
DTXSID7031797- ChEMBL
CHEMBL57- ChEBI
CHEBI:63613- UNII
- 99DK7FVK1H
- EC Number
- 603-345-0
- Nikkaji
- J420.601K
物性
構造計算による物性
- XLogP
- 2
- 極性表面積
- 58.1 Ų
- 水素結合供与体数
- 1
- 水素結合受容体数
- 4
- 回転可能結合数
- 1
- 重原子数
- 20
- 形式電荷
- 0
- 複雑度
- 397
物理化学的性質
- 融点
- 247 °C · 247°C
- 沸点
- 409.5 °C · 409.5°C (rough estimate)
- 比重(密度)
- 1.13 · 1.1300 (rough estimate)
- 屈折率
- 1.62 · 1.6200 (estimate)
- 闪点
- 9 ℃ · 9℃
- 貯蔵温度
- 2 · 2-8°C
- 溶解性
- 22 mg/mL以上 · DMSO:22mg/mL以上
- 外見
- 粉
- 酸解離定数(Pka)
- 2.8 · 2.8(at 25℃)
- 色
- 白から黄褐色
- 水溶解度
- 0.1 g/L · 0.1g/L(温度表記なし)
- Merck
- 14 · 14,6490
- BCS Class
- 2 · 2
- 主な用途
- 医薬品(低分子化合物)
- InChI
- 1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)
- InChIKey
- NQDJXKOVJZTUJA-UHFFFAOYSA-N
- SMILES
- CC1=CC=NC2=C1NC(C(C=CC=N3)=C3N2C4CC4)=O
- CAS データベース
- 129618 · 129618-40-2(CAS DataBase Reference)
- EPAの化学物質情報
- 6 H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, · 6H-Dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl- (129618-40-2)
化学的性質
化学的特性Crystalline Solid
安全と法規制
安全データ
- wgk
- 2
- rtecs
- JM5562500
- ridadr
- UN1230 - class 3 - PG 2 - Methanol, solution
- hs_code
- 29339900
- risk_code
- 36/37/38
- hazard_code
- Xi
- safety_code
- 26-36-37/39
- ストレージクラス
- 11 - Combustible Solids
- 有毒物質データの
- 129618-40-2(Hazardous Substances Data)
化学と産業
応用分野
用途抗HIV薬
説明Nevirapine and its analogues exhibit antiretroviral effect against azothymidine-resistant HIV strains. Nevirapine in combination with ZDV and ddI produced approximately 18% higher CD4 cell counts and a decrease in viral load compared with patients who took ZDV and ddI. Nevirapine is recommended with nucleosides for patients infected with HIV-1 who have experienced clinical or immunologic deterioration. The significant side effects of nevirapine are liver dysfunction and skin rashes.
使用Labelled Nevirapine , a potent (IC50=84nM) and selective non-nucleoside inhibitor of HIV-1 reverse transcriptase. Antiviral.;Labeled Nevirapine, intended for use as an internal standard for the quantification of Nevirapine by GC- or LC-mass spectrometry.
一般的な説明Nevirapine (Viramune) is more than 90% absorbed by theoral route and is widely distributed throughout the body. Itdistributes well into breast milk and crosses the placenta.Transplacental concentrations are about 50% those ofserum. The drug is extensively transformed by cytochromeP450 (CYP) to inactive hydroxylated metabolites; it mayundergo enterohepatic recycling.
上流・下流製品情報
上流原料
下流製品
サプライヤー50 社
補足説明
定義ChEBI: A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse tr nscriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
関連反応
関連ノート
読み込み中…